Douglas Tremblay, MD
AML Specialist
Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms.
Mount Sinai Health System: 1470 Madison Ave #6th, New York, NY 10029, USA